Phase IV studies may involve which of the following activities?

• A. Development of an application unrelated to the original approved use after initial approval
• B. New or modified indications
• C. Preclinical toxicity testing
• D. Clinical trials in healthy volunteers

Answer: (A)

Phase IV studies are conducted after a product has been approved and marketed, often to monitor long-term safety and to gather information that can lead to changes in how the product is used. A common Phase IV activity is pursuing regulatory actions to expand the labeled use of the product, which requires the development and submission of a supplemental application to extend or modify the original approval. This is why development of an application to extend the approved use fits Phase IV well—it happens post-approval and involves regulatory planning to broaden the product’s indications.

Preclinical toxicity testing is done before human trials and reflects earlier stages of development, not Phase IV. Trials in healthy volunteers are characteristic of Phase I and occur well before approval. While exploring new or modified indications can occur in Phase IV, the specific item described best fits the regulatory expansion activity that follows initial approval.